Waystar Holding Corp. (WAY): Results of Operations and Financial Condition
Waystar Holding Corp. (WAY) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 way072926-8xkex991.htm EX-99.1 Document Waystar Reports Second Quarter 2026 Results Q2 revenue of $319.7M, up 18% YoY Q2 net income of $40.9M and non-GAAP net income of $83.3M Q2 net income margin of 13%; adjusted EBITDA margin of 43% Raising revenue and adjusted EBITDA
How this was made
The 30-second read
Why it matters
The combination of strong Q2 growth, high adjusted EBITDA margin, and raised FY2026 revenue and adjusted EBITDA ranges provides a concrete catalyst for re-pricing expectations and updating models.
Market read
Traders can update valuation and positioning based on the newly disclosed Q2 datapoints and the raised FY2026 guidance ranges.
What to watch
The release emphasizes non-GAAP metrics; traders may discount adjusted EBITDA quality and watch for any GAAP-to-non-GAAP reconciliation items or working-capital swings affecting future cash flow.
Background
This is Waystar’s SEC Form 8-K furnishing Q2 2026 results and full-year 2026 guidance, plus a scheduled earnings call.
Ticker impact
Waystar reported Q2 2026 revenue of $319.7M (+18% YoY) and raised FY2026 revenue and adjusted EBITDA guidance in its 8-K.
Likely positive bias for the next session and into the earnings call, with upside follow-through if guidance is viewed as credible and margins hold.
The filing includes both detailed Q2 results (revenue, net income, adjusted EBITDA, FCF) and explicit full-year guidance ranges, which are direct inputs to valuation and positioning.
Market effects
Signals continued demand and monetization strength in healthcare payment software, potentially supporting sentiment for adjacent provider-payer infrastructure vendors.
Limited direct regional read-through; primarily a US-listed healthcare software name.
Mostly domestic US healthcare payments; limited direct global macro linkage beyond risk-on tech/software sentiment.
Counterpoint
Guidance raises may already be partially anticipated; investors could focus on sustainability of retention (NRR) and volume-based growth rather than headline revenue.
Key entities
- companyWaystar Holding Corp.
Provider of healthcare payment software; reported Q2 2026 results and raised FY2026 guidance.
- personMatt Hawkins
CEO quoted in the release regarding demand, execution, provider adoption, and AltitudeAI impact.